2011China Modern DoctorRequires access

The Clinical Observation of Cyclosporin A Combined with Stanozolol Used in Chronic Aplastic Anemia

Tao Wu

Open publisher page 0 citations

Abstract

Objective To observe the clinical effect of cyclosporin A combined stanozolol treated in chronic aplastic anemia(CAA).Methods All 52 cases chronic aplastic anemia were randomly divided into control group and observation group.Control group:a single treatment with stanozolol,the observation group were based on combined cyclosporine,to compare the efficacy of the two groups before and after treatment,and to observe the changes of peripheral blood neutrophils,hemoglobin,reticulocyte and platelet.Results The total efficiency of the observation group was 76.9%,it was higher than the control group(53.8%)(P0.05).After treatment,neutrophils,hemoglobin,reticulocytes,platelets was significantly improved and compared with before treatment,and the observation group was significantly improved than the control group(P0.05).Conclusion Cyclosporin A combined with stanozolol used in treatment of chronic aplastic anemia is reliable,safe,and it should be widely promoted and applications.

About this research paper

What this paper is about

Objective To observe the clinical effect of cyclosporin A combined stanozolol treated in chronic aplastic anemia(CAA).Methods All 52 cases chronic aplastic anemia were randomly divided into control group and observation group.Control group:a single treatment with stanozolol,the observation group were based on combined cyclosporine,to compare the efficacy of the two groups before and after treatment,and to observe the changes of peripheral blood neutrophils,hemoglobin,reticulocyte and platelet.Results The total efficiency of the observation group was 76.9%,it was higher than the control group(53.8%)(P0.05).After treatment,neutrophils,hemoglobin,reticulocytes,platelets was significantly improved and compared with before treatment,and the observation group was significantly improved than the control group(P0.05).Conclusion Cyclosporin A combined with stanozolol used in treatment of chronic aplastic anemia is reliable,safe,and it should be widely promoted and applications.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the clinical effect of cyclosporin A combined stanozolol treated in chronic aplastic anemia(CAA).Methods All 52 cases chronic aplastic anemia were randomly divided into control group and observation group.Control group:a single treatment with stanozolol,the observation group were based on combined cyclosporine,to compare the efficacy of the two groups before and after treatment,and to observe the changes of peripheral blood neutrophils,hemoglobin,reticulocyte and platelet.Results The total efficiency of the observation group was 76.9%,it was higher than the control group(53.8%)(P0.05).After treatment,neutrophils,hemoglobin,reticulocytes,platelets was significantly improved and compared with before treatment,and the observation group was significantly improved than the control group(P0.05).Conclusion Cyclosporin A combined with stanozolol used in treatment of chronic aplastic anemia is reliable,safe,and it should be widely promoted and applications.

Key concepts: Stanozolol, Medicine, Aplastic anemia, Hemoglobin, Reticulocyte, Gastroenterology, Internal medicine, Platelet

Related papers

Back to paper searchBrowse research topicsOriginal source
The Clinical Observation of Cyclosporin A Combined with Stanozolol Used in Chronic Aplastic Anemia — Research Paper | ScholarLens